Panel Nixes Pfizer Fraudulent Marketing MDL

Law360, New York (December 2, 2009, 4:07 PM EST) -- Two lead plaintiffs accusing Pfizer Inc. of fraudulently promoting and lying about the safety of 11 prescription drugs including Viagra and Zoloft have lost a bid to centralize their actions as multidistrict litigation.

The U.S. Judicial Panel on Multidistrict Litigation denied the motion for centralization on Tuesday, saying that even though the two suits shared allegations, it questioned whether the lead plaintiffs would be able to prosecute all of the claims in each complaint.

The suits, brought in the Eastern District of Pennsylvania and the District...
To view the full article, register now.